Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 51(6): e7238, 2018. tab, graf
Article Dans Anglais | LILACS | ID: biblio-889106

Résumé

Ulomoides dermestoides is a beetle traditionally consumed to treat diabetes. In this study, we performed a composition analysis of U. dermestoides to obtain the principal fractions, which were used to assess the effect on glycemia, liver and pancreatic architecture, and PPARγ and GLUT4 expression. Normal mice and alloxan-induced diabetic mice were administered fractions of chitin, protein or fat, and the acute hypoglycemic effect was evaluated. A subacute study involving daily administration of these fractions to diabetic mice was also performed over 30 days, after which the liver and pancreas were processed by conventional histological techniques and stained with hematoxylin and eosin to evaluate morphological changes. The most active fraction, the fat fraction, was analyzed by gas chromatography-mass spectrometry (GC-MS), and PPARγ and GLUT4 mRNA expressions were determined in 3T3-L1 adipocytes. The protein and fat fractions exhibited hypoglycemic effects in the acute as well as in the 30-day study. Only the fat fraction led to elevated insulin levels and reduced glycemia, as well as lower intake of water and food. In the liver, we observed recovery of close hepatic cords in the central lobule vein following treatment with the fat fraction, while in the pancreas there was an increased density and percentage of islets and number of cells per islet, suggesting cellular regeneration. The GC-MS analysis of fat revealed three fatty acids as the major components. Finally, increased expression of PPARγ and GLUT4 was observed in 3T3-L1 adipocytes, indicating an antidiabetic effect.


Sujets)
Animaux , Mâle , Pancréas/effets des médicaments et des substances chimiques , Extraits tissulaires/usage thérapeutique , Coléoptères/composition chimique , Corps gras/composition chimique , Hypoglycémiants/usage thérapeutique , Foie/effets des médicaments et des substances chimiques , Pancréas/métabolisme , Pancréas/anatomopathologie , Extraits tissulaires/isolement et purification , ARN messager/effets des médicaments et des substances chimiques , ARN messager/métabolisme , Régulation de l'expression des gènes , Récepteur PPAR gamma/effets des médicaments et des substances chimiques , Récepteur PPAR gamma/métabolisme , Diabète expérimental/métabolisme , Diabète expérimental/anatomopathologie , Diabète expérimental/traitement médicamenteux , Transporteur de glucose de type 4/effets des médicaments et des substances chimiques , Transporteur de glucose de type 4/métabolisme , Hypoglycémiants/isolement et purification , Foie/métabolisme , Foie/anatomopathologie , Chromatographie gazeuse-spectrométrie de masse
SÉLECTION CITATIONS
Détails de la recherche